These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37952805)

  • 1. RecA inhibitor epicatechin prolongs the development of fluoroquinolone resistance in Pasteurella multocida.
    Xu G; Li P; Xue Z; Qi Y; Li X; Zhu D; Ma H; Kong L
    Int J Biol Macromol; 2024 Jan; 255():128026. PubMed ID: 37952805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bactericidal activity of ciprofloxacin and sparfloxacin. Comparison with others active antibiotics against Pasteurella multocida].
    Gastine C; Donnio PY; Travert MF; Avril JL
    Presse Med; 1995 Mar; 24(11):519-22. PubMed ID: 7770389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
    Sweeney MT; Papich MG; Watts JL
    J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility and molecular typing of Pasteurella multocida isolated from six provinces in China.
    Kong LC; Wang Z; Wang YM; Dong WL; Jia BY; Gao D; Jiang XY; Ma HX
    Trop Anim Health Prod; 2019 May; 51(4):987-992. PubMed ID: 30535896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone resistance mechanism of clinical isolates and selected mutants of Pasteurella multocida from bovine respiratory disease in China.
    Kong LC; Gao D; Gao YH; Liu SM; Ma HX
    J Vet Med Sci; 2014 Dec; 76(12):1655-7. PubMed ID: 25649952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of systemic fluoroquinolone administration on the presence of Pasteurella multocida in the upper respiratory tract of clinically healthy calves.
    Catry B; Croubels S; Schwarz S; Deprez P; Cox B; Kehrenberg C; Opsomer G; Decostere A; Haesebrouck F
    Acta Vet Scand; 2008 Sep; 50(1):36. PubMed ID: 18808692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance of Pasteurella multocida isolated from diseased food-producing animals and pets.
    Bourély C; Cazeau G; Jouy E; Haenni M; Madec JY; Jarrige N; Leblond A; Gay E
    Vet Microbiol; 2019 Aug; 235():280-284. PubMed ID: 31383313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and ex vivo antibacterial activity of levofloxacin against Pasteurella multocida and Escherichia coli isolated from rabbits (Oryctolagus cuniculus) - A preliminary study.
    Sitovs A; Skadins I; Purvina S; Bandere D
    J Vet Pharmacol Ther; 2023 Sep; 46(5):332-343. PubMed ID: 37060264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration-resistance relationship and PK/PD evaluation of danofloxacin against emergence of resistant Pasteurella multocida in an in vitro dynamic model.
    Lu TY; Sun Z; Liang LY; Zhang J; Guo WL; Wang ZY; Sun J; Liao XP; Zhou YF
    J Appl Microbiol; 2024 Jul; 135(7):. PubMed ID: 38925653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcriptional response of Pasteurella multocida to three classes of antibiotics.
    Nanduri B; Shack LA; Burgess SC; Lawrence ML
    BMC Genomics; 2009 Jul; 10 Suppl 2(Suppl 2):S4. PubMed ID: 19607655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
    Grobbel M; Lübke-Becker A; Wieler LH; Froyman R; Friederichs S; Filios S
    Vet Microbiol; 2007 Sep; 124(1-2):73-81. PubMed ID: 17498893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside susceptibility of Pasteurella multocida isolates from bovine respiratory infections in China and mutations in ribosomal protein S5 associated with high-level induced spectinomycin resistance.
    Wang Z; Kong LC; Jia BY; Liu SM; Jiang XY; Ma HX
    J Vet Med Sci; 2017 Oct; 79(10):1678-1681. PubMed ID: 28867688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment history and antimicrobial susceptibility results for Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolates from bovine respiratory disease cases submitted to the Iowa State University Veterinary Diagnostic Laboratory from 2013 to 2015.
    Magstadt DR; Schuler AM; Coetzee JF; Krull AC; O'Connor AM; Cooper VL; Engelken TJ
    J Vet Diagn Invest; 2018 Jan; 30(1):99-104. PubMed ID: 29034785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.
    Shan Q; Wang J; Yang F; Ding H; Liang C; Lv Z; Li Z; Zeng Z
    J Vet Pharmacol Ther; 2014 Jun; 37(3):222-30. PubMed ID: 24033339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of spectinomycin and comparator agents against Pasteurella multocida and Mannheimia haemolytica from respiratory tract infections of cattle.
    Schwarz S; Kehrenberg C; Salmon SA; Watts JL
    J Antimicrob Chemother; 2004 Feb; 53(2):379-82. PubMed ID: 14729757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of florfenicol-resistant Pasteurella multocida isolates in Germany.
    Kehrenberg C; Wallmann J; Schwarz S
    J Antimicrob Chemother; 2008 Nov; 62(5):951-5. PubMed ID: 18786941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of a multiresistant Pasteurella multocida strain isolated from cattle.
    Ujvári B; Makrai L; Magyar T
    Acta Vet Hung; 2018 Mar; 66(1):12-19. PubMed ID: 29580078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial efficacy and pharmacokinetic studies of ciprofloxacin on Pasteurella multocida infected rabbits.
    Hanan MS; Riad EM; el-Khouly NA
    Dtsch Tierarztl Wochenschr; 2000 Apr; 107(4):151-5. PubMed ID: 10829566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICEPmu1, an integrative conjugative element (ICE) of Pasteurella multocida: analysis of the regions that comprise 12 antimicrobial resistance genes.
    Michael GB; Kadlec K; Sweeney MT; Brzuszkiewicz E; Liesegang H; Daniel R; Murray RW; Watts JL; Schwarz S
    J Antimicrob Chemother; 2012 Jan; 67(1):84-90. PubMed ID: 22001175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.